Ohio doctor develops fast self-testing for COVID-19

Article Source: https://spectrumnews1.com



July 7, 2021



Biologics, Check4, Covid, Press

Ohio State Medical School graduate, trauma surgeon and entrepreneur Dr. Gregory Hummer was enjoying retirement when the COVID-19 pandemic hit. He wanted to be part of the solution and was frustrated by the slow speed and inaccuracy of PCR testing. So he took a look at some technology he had been working on at Case Western Reserve University a decade earlier.

MEDIA & PRESS INQUIRES

CONNECT WITH IDENTIFYSENSORS

Communications: Joe Mosbrook
(216) 375-2141
mosbrook@acclaimllc.com

FORMER LUCIRA EVP AND CQO JOINS IDENTIFYSENSORS AS EVP AND CHIEF QUALITY OFFICER

Feb 21, 2023 | Biologics, Press

Cleveland – IdentifySensors Biologics, along with leading researchers at Purdue University, developed a breakthrough technology that intends to reshape the future of diagnostic testing. It is their innovative nanosensor technology, Check4™, that won them the 2021...

IDENTIFYSENSORS BIOLOGICS REACHES BREAKTHROUGH SENSITIVITY LEVELS WITH NEW DIGITAL DIAGNOSTICS PLATFORM

Jan 4, 2023 | App, Biologics, Check4, Covid, Press

Cleveland – IdentifySensors Biologics, along with leading researchers at Purdue University, developed a breakthrough technology that intends to reshape the future of diagnostic testing. It is their innovative nanosensor technology, Check4™, that won them the 2021...

IDENTIFYSENSORS HAS FINALIZED PROOF-OF-CONCEPT RESEARCH FOR ALL-NEW COVID TESTING METHOD

Feb 2, 2022 | App, Biologics, Check4, Covid, Press

Cleveland – IdentifySensors Biologics, along with leading researchers at Purdue University, developed a breakthrough technology that intends to reshape the future of diagnostic testing. It is their innovative nanosensor technology, Check4™, that won them the 2021...

July 7, 2021

Biologics, Check4, Covid, Press

MEDIA & PRESS INQUIRES

CONNECT WITH IDENTIFYSENSORS

Related Articles

FORMER LUCIRA EVP AND CQO JOINS IDENTIFYSENSORS AS EVP AND CHIEF QUALITY OFFICER

IDENTIFYSENSORS BIOLOGICS REACHES BREAKTHROUGH SENSITIVITY LEVELS WITH NEW DIGITAL DIAGNOSTICS PLATFORM

IDENTIFYSENSORS HAS FINALIZED PROOF-OF-CONCEPT RESEARCH FOR ALL-NEW COVID TESTING METHOD

Press & Highlights

How is Check4™ different from other tests?

FORMER LUCIRA EVP AND CQO JOINS IDENTIFYSENSORS AS EVP AND CHIEF QUALITY OFFICER

IDENTIFYSENSORS BIOLOGICS REACHES BREAKTHROUGH SENSITIVITY LEVELS WITH NEW DIGITAL DIAGNOSTICS PLATFORM

IDENTIFYSENSORS HAS FINALIZED PROOF-OF-CONCEPT RESEARCH FOR ALL-NEW COVID TESTING METHOD

IDENTIFYSENSORS BIOLOGICS RECEIVES TECHOHIO START-UP AWARD

IdentifySensors Technology Platform uses Electronic Nanosensors to Detect Genetic Materials

IdentifySensors Develops Fast, Accurate, Over-the-counter RNA Self-test

IdentifySensors Biologics Moves New Pathogen Testing Platform To Commercialization Stage

Purdue Research Foundation partners with IdentifySensors

Ohio doctor develops fast self-testing for COVID-19

Check4-COVID by IdentifySensors Biologics Allows For Accurate Results Within Minutes On Your Phone

Bloomberg Business – IdentifySensors Biologics Develops Fast, Accurate, Over-the-counter RNA COVID Self-test

Cleveland based IdentifySensors developing rapid, at-home COVID-19 test

MEDIA & PRESS INQUIRES

Request
Information

SOLUTIONS

COMPANY